Cargando…
Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
Mild hypercortisolism is defined as biochemical evidence of abnormal cortisol secretion without the classical detectable manifestations of overt Cushing’s syndrome and, above all, lacking catabolic characteristics such as central muscle weakness, adipose tissue redistribution, skin fragility and unu...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775422/ https://www.ncbi.nlm.nih.gov/pubmed/35054858 http://dx.doi.org/10.3390/ijms23020673 |
_version_ | 1784636581378785280 |
---|---|
author | Favero, Vittoria Cremaschi, Arianna Parazzoli, Chiara Falchetti, Alberto Gaudio, Agostino Gennari, Luigi Scillitani, Alfredo Vescini, Fabio Morelli, Valentina Aresta, Carmen Chiodini, Iacopo |
author_facet | Favero, Vittoria Cremaschi, Arianna Parazzoli, Chiara Falchetti, Alberto Gaudio, Agostino Gennari, Luigi Scillitani, Alfredo Vescini, Fabio Morelli, Valentina Aresta, Carmen Chiodini, Iacopo |
author_sort | Favero, Vittoria |
collection | PubMed |
description | Mild hypercortisolism is defined as biochemical evidence of abnormal cortisol secretion without the classical detectable manifestations of overt Cushing’s syndrome and, above all, lacking catabolic characteristics such as central muscle weakness, adipose tissue redistribution, skin fragility and unusual infections. Mild hypercortisolism is frequently discovered in patients with adrenal incidentalomas, with a prevalence ranging between 5 and 50%. This high variability is mainly due to the different criteria used for defining this condition. This subtle cortisol excess has also been described in patients with incidentally discovered pituitary tumors with an estimated prevalence of 5%. To date, the mechanisms responsible for the pathogenesis of mild hypercortisolism of pituitary origin are still not well clarified. At variance, recent advances have been made in understanding the genetic background of bilateral and unilateral adrenal adenomas causing mild hypercortisolism. Some recent data suggest that the clinical effects of glucocorticoid (GC) exposure on peripheral tissues are determined not only by the amount of the adrenal GC production but also by the peripheral GC metabolism and by the GC sensitivity. Indeed, in subjects with normal cortisol secretion, the combined estimate of cortisol secretion, cortisone-to-cortisol peripheral activation by the 11 beta-hydroxysteroid dehydrogenase enzyme and GC receptor sensitizing variants have been suggested to be associated with the presence of hypertension, diabetes and bone fragility, which are three well-known consequences of hypercortisolism. This review focuses on the pathophysiologic mechanism underlying both the different sources of mild hypercortisolism and their clinical consequences (bone fragility, arterial hypertension, subclinical atherosclerosis, cardiovascular remodeling, dyslipidemia, glucose metabolism impairment, visceral adiposity, infections, muscle damage, mood disorders and coagulation). |
format | Online Article Text |
id | pubmed-8775422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87754222022-01-21 Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside Favero, Vittoria Cremaschi, Arianna Parazzoli, Chiara Falchetti, Alberto Gaudio, Agostino Gennari, Luigi Scillitani, Alfredo Vescini, Fabio Morelli, Valentina Aresta, Carmen Chiodini, Iacopo Int J Mol Sci Review Mild hypercortisolism is defined as biochemical evidence of abnormal cortisol secretion without the classical detectable manifestations of overt Cushing’s syndrome and, above all, lacking catabolic characteristics such as central muscle weakness, adipose tissue redistribution, skin fragility and unusual infections. Mild hypercortisolism is frequently discovered in patients with adrenal incidentalomas, with a prevalence ranging between 5 and 50%. This high variability is mainly due to the different criteria used for defining this condition. This subtle cortisol excess has also been described in patients with incidentally discovered pituitary tumors with an estimated prevalence of 5%. To date, the mechanisms responsible for the pathogenesis of mild hypercortisolism of pituitary origin are still not well clarified. At variance, recent advances have been made in understanding the genetic background of bilateral and unilateral adrenal adenomas causing mild hypercortisolism. Some recent data suggest that the clinical effects of glucocorticoid (GC) exposure on peripheral tissues are determined not only by the amount of the adrenal GC production but also by the peripheral GC metabolism and by the GC sensitivity. Indeed, in subjects with normal cortisol secretion, the combined estimate of cortisol secretion, cortisone-to-cortisol peripheral activation by the 11 beta-hydroxysteroid dehydrogenase enzyme and GC receptor sensitizing variants have been suggested to be associated with the presence of hypertension, diabetes and bone fragility, which are three well-known consequences of hypercortisolism. This review focuses on the pathophysiologic mechanism underlying both the different sources of mild hypercortisolism and their clinical consequences (bone fragility, arterial hypertension, subclinical atherosclerosis, cardiovascular remodeling, dyslipidemia, glucose metabolism impairment, visceral adiposity, infections, muscle damage, mood disorders and coagulation). MDPI 2022-01-08 /pmc/articles/PMC8775422/ /pubmed/35054858 http://dx.doi.org/10.3390/ijms23020673 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Favero, Vittoria Cremaschi, Arianna Parazzoli, Chiara Falchetti, Alberto Gaudio, Agostino Gennari, Luigi Scillitani, Alfredo Vescini, Fabio Morelli, Valentina Aresta, Carmen Chiodini, Iacopo Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside |
title | Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside |
title_full | Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside |
title_fullStr | Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside |
title_full_unstemmed | Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside |
title_short | Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside |
title_sort | pathophysiology of mild hypercortisolism: from the bench to the bedside |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775422/ https://www.ncbi.nlm.nih.gov/pubmed/35054858 http://dx.doi.org/10.3390/ijms23020673 |
work_keys_str_mv | AT faverovittoria pathophysiologyofmildhypercortisolismfromthebenchtothebedside AT cremaschiarianna pathophysiologyofmildhypercortisolismfromthebenchtothebedside AT parazzolichiara pathophysiologyofmildhypercortisolismfromthebenchtothebedside AT falchettialberto pathophysiologyofmildhypercortisolismfromthebenchtothebedside AT gaudioagostino pathophysiologyofmildhypercortisolismfromthebenchtothebedside AT gennariluigi pathophysiologyofmildhypercortisolismfromthebenchtothebedside AT scillitanialfredo pathophysiologyofmildhypercortisolismfromthebenchtothebedside AT vescinifabio pathophysiologyofmildhypercortisolismfromthebenchtothebedside AT morellivalentina pathophysiologyofmildhypercortisolismfromthebenchtothebedside AT arestacarmen pathophysiologyofmildhypercortisolismfromthebenchtothebedside AT chiodiniiacopo pathophysiologyofmildhypercortisolismfromthebenchtothebedside |